YÜKSEL, M. Et Al. 2017. A Biosimiliar G-CSF filgrastim is as effective as a reference drug however it is not cost effective as supposed to be and by the way no impact on the health care system. 43rdAnnual Meeting of the European Society for Blood and Marrow Transplantation .

YÜKSEL, M., PEKCAN, G., ŞAHİN, U., CİVRİZ BOZDAĞ, S., TOPRAK, S. K., TOPÇUOĞLU, P., ... ARSLAN, Ö.(2017). A Biosimiliar G-CSF filgrastim is as effective as a reference drug however it is not cost effective as supposed to be and by the way no impact on the health care system . 43rdAnnual Meeting of the European Society for Blood and Marrow Transplantation

YÜKSEL, MELTEM Et Al. "A Biosimiliar G-CSF filgrastim is as effective as a reference drug however it is not cost effective as supposed to be and by the way no impact on the health care system," 43rdAnnual Meeting of the European Society for Blood and Marrow Transplantation, 2017

YÜKSEL, MELTEM Et Al. "A Biosimiliar G-CSF filgrastim is as effective as a reference drug however it is not cost effective as supposed to be and by the way no impact on the health care system." 43rdAnnual Meeting of the European Society for Blood and Marrow Transplantation , 2017

YÜKSEL, M. Et Al. (2017) . "A Biosimiliar G-CSF filgrastim is as effective as a reference drug however it is not cost effective as supposed to be and by the way no impact on the health care system." 43rdAnnual Meeting of the European Society for Blood and Marrow Transplantation .

@conferencepaper{conferencepaper, author={MELTEM YÜKSEL Et Al. }, title={A Biosimiliar G-CSF filgrastim is as effective as a reference drug however it is not cost effective as supposed to be and by the way no impact on the health care system}, congress name={43rdAnnual Meeting of the European Society for Blood and Marrow Transplantation}, city={}, country={}, year={2017}}